UniQuest and CCRM sign international deal to develop treatment for chemotherapy-induced Neutropenia
Patients at risk of life-threatening infections following chemotherapy could…
‘Probiotics’ on salad greens could make them safer, healthier
Friendly bacteria may be introduced to bagged salad leaves to help ward…
UQ medical research recognised on national stage
Two companies founded on University of Queensland research have won acclaim at…
UniQuest congratulates Redback Technologies on Series A Investment
UniQuest has congratulated Redback Technologies following the company’s…
UQ sewer technology bound for international markets
A treatment developed at The University of Queensland to control sewer odour…
Three projects funded in open innovation collaboration with AstraZeneca
Three projects selected to receive funding under an “open innovation” program…
New company tackling chronic inflammatory diseases secures A$22m in series A financing
Inflazome Ltd, a company founded on molecules and associated intellectual…
UniQuest congratulates Protagonist on initial public offering
UniQuest congratulates Protagonist Therapeutics Inc. on the news that the…
UniQuest congratulates ResApp Health on first US clinical study site
UniQuest congratulates ResApp Health Limited (ASX:RAP) following the company’s…
New UQ partnership to focus on university-industry collaboration
The University of Queensland has become the first Australian institution to be…